The Medicines and Healthcare products Regulatory Agency (MHRA) has today (14 August 2026) approved vimseltinib (romvimza) to treat adult patients with tenosynovial…
There’s something the tens of millions of Americans who are currently on GLP-1 medications, or thinking of starting them, need to know. When patients rapidly…